InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
19,255.22
(
2.11%
)
Dow Jones
41,503.10
(
0.00%
)
Brent Oil
73.85
(
2.02%
)
Bitcoin
62,909.26
(
2.01%
)
Post# of 253153
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 189373

Monday, 03/30/2015 3:13:03 PM

Monday, March 30, 2015 3:13:03 PM

Post# of 253153
PBM consolidation will boost payers’ leverage (duh):

http://www.bloomberg.com/news/articles/2015-03-30/insurer-fight-on-pricey-drugs-to-intensify-after-catamaran-deal

Once UnitedHealth’s $12.8 billion acquisition closes, 75% of prescriptions filled in the U.S. will be in the hands of three players.

OptumRx, UnitedHealth’s drug benefit arm, covers about 30 million people, while Catamaran represents about 35 million. [I.e. the merged UNH-VTRX will cover 65M lives.] That compares with about 90 million people for Express Scripts and more than 65 million for CVS.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up